Sanofi (SNYNF) EBT Margin (QoQ) (2009 - 2026)

Sanofi (SNYNF) EBT Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Sanofi - - 9.49 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 25,936.00
Dec 31, 2025 -26,054.00
Sep 30, 2025 -426.00
Jun 30, 2025 223.00
Mar 31, 2025 -25,740.00
Dec 31, 2024 26,625.00
Sep 30, 2024 -1,215.00
Jun 30, 2024 -238.00
Mar 31, 2024 1,158.00
Dec 31, 2023 171.00
Sep 30, 2023 -740.00
Jun 30, 2023 77.00
Mar 31, 2023 -7,158.00
Dec 31, 2022 7,904.00
Sep 30, 2022 -952.00
Jun 30, 2022 614.00
Mar 31, 2022 11,700.00
Dec 31, 2021 -11,098.00
Sep 30, 2021 -579.00
Jun 30, 2021 118.00